Literature DB >> 12052339

Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.

Ya-Wen Hsiao1, Kuang-Wen Liao, Shao-Wen Hung, Rea-Min Chu.   

Abstract

Canine transmissible venereal tumor (CTVT) can be allo-transplanted across major histocompatibility complex barriers. The expression of MHC molecules is usually low in the progression (P) stage and then greatly increases during tumor regression (R). We investigated the effects of tumor infiltrating lymphocytes (TIL) on the expression of MHC molecules of CTVT cells. Isolated, viable CTVT cells were inoculated at each of 12 sites (1 x 10(8) CTVT cells per site) on the back of six, mixed-breed dogs. Tumor masses were collected every 2-3 weeks and prepared for histopathologic, immunocytochemistry, flow cytometry and immunoblotting studies. The level of MHC expression on tumor cells from different stages of growth was measured. Initially, expression of MHC I and II molecules in P phase CTVT was low. Twelve weeks post-inoculation (PI), expression increased dramatically and it continued to increase during R phase. Tumor growth slowed after 12 weeks PI and tumors entered R phase around 17 weeks PI. We hypothesize that CTVT evades host immunosurveillance and grows progressively for 12 weeks, when it becomes vulnerable and subject to the host's anti-tumor immune responses. We further demonstrated that R phase, but not P phase, TIL were closely associated with the over-expression of MHC I and II molecules by CTVT cells. The number and proportion of TIL were higher in R phase tumors. Supernatants, from R phase co-cultures (CTVT+TIL) and TIL only, promoted MHC I and II expression on P phase CTVT cells. After culturing alone for 1 month, expression of MHC classes I and II molecules in R phase CTVT cells decreased to the level of P phase CTVT cells. However, the above-mentioned supernatants restored their expression of MHC I and II molecules. In contrast, supernatants from P phase TIL or CTVT cells increased expression slightly or had no effect. Therefore, TIL, not CTVT cells, produce the effective substance (s) to promote the expression of MHC molecules by the tumor cells. Heat treated supernatant was unable to promote the expression of MHC I and II molecules by CTVT cells. In conclusion, TIL isolated from R phase CTVT secreted a heat-sensitive, soluble substance(s) that triggered over-expression of MHC I and II after 12 weeks PI. This caused the tumor to enter R phase and helped stop CTVT growth. Our findings will facilitate the understanding and further investigation of the mechanisms that initiate host immune surveillance against tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052339     DOI: 10.1016/s0165-2427(02)00026-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  12 in total

1.  SJSZ glycoprotein (38 kDa) modulates expression of IL-2, IL-12, and IFN-γ in cyclophosphamide-induced Balb/c.

Authors:  Jin Lee; Kye-Taek Lim
Journal:  Inflamm Res       Date:  2012-07-20       Impact factor: 4.575

Review 2.  The role of the Major Histocompatibility Complex in the spread of contagious cancers.

Authors:  Katherine Belov
Journal:  Mamm Genome       Date:  2010-10-21       Impact factor: 2.957

3.  Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.

Authors:  Chrissie E B Ong; Yuanyuan Cheng; Hannah V Siddle; A Bruce Lyons; Gregory M Woods; Andrew S Flies
Journal:  Open Biol       Date:  2022-10-19       Impact factor: 7.124

4.  Evolution of a contagious cancer: epigenetic variation in Devil Facial Tumour Disease.

Authors:  Beata Ujvari; Anne-Maree Pearse; Sarah Peck; Collette Harmsen; Robyn Taylor; Stephen Pyecroft; Thomas Madsen; Anthony T Papenfuss; Katherine Belov
Journal:  Proc Biol Sci       Date:  2012-11-07       Impact factor: 5.349

5.  Immunology of naturally transmissible tumours.

Authors:  Hannah V Siddle; Jim Kaufman
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

6.  Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.

Authors:  Ruth Pye; Rodrigo Hamede; Hannah V Siddle; Alison Caldwell; Graeme W Knowles; Kate Swift; Alexandre Kreiss; Menna E Jones; A Bruce Lyons; Gregory M Woods
Journal:  Biol Lett       Date:  2016-10       Impact factor: 3.703

Review 7.  IL-12 based gene therapy in veterinary medicine.

Authors:  Darja Pavlin; Maja Cemazar; Gregor Sersa; Natasa Tozon
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

8.  Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.

Authors:  Hsin-Chien Chiang; Yu-Shan Wang; Chung-Hsi Chou; Albert Taiching Liao; Rea-Min Chu; Chen-Si Lin
Journal:  BMC Vet Res       Date:  2012-11-09       Impact factor: 2.741

9.  The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.

Authors:  Alison Caldwell; Rachel Coleby; Cesar Tovar; Maximilian R Stammnitz; Young Mi Kwon; Rachel S Owen; Marios Tringides; Elizabeth P Murchison; Karsten Skjødt; Gareth J Thomas; Jim Kaufman; Tim Elliott; Gregory M Woods; Hannah Vt Siddle
Journal:  Elife       Date:  2018-08-14       Impact factor: 8.140

Review 10.  Testing the theory of immune selection in cancers that break the rules of transplantation.

Authors:  Ariberto Fassati; N Avrion Mitchison
Journal:  Cancer Immunol Immunother       Date:  2009-12-22       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.